RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
YY Syed - Drugs & Therapy Perspectives, 2022 - Springer
Abstract RTS, S/AS01 (Mosquirix®) is a vaccine against malaria caused by Plasmodium
falciparum. In a phase 3 trial, RTS, S/AS01 showed vaccine efficacy against clinical malaria …
falciparum. In a phase 3 trial, RTS, S/AS01 showed vaccine efficacy against clinical malaria …
Impacts of ecology, parasite antigenic variation, and human genetics on RTS, S/AS01e malaria vaccine efficacy
Abstract Purpose of Review Global malaria elimination has little chance of success without
an effective vaccine. The first malaria vaccine, RTS, S/AS01e, demonstrated moderate …
an effective vaccine. The first malaria vaccine, RTS, S/AS01e, demonstrated moderate …
Malaria transmission intensity likely modifies RTS, S/AS01 efficacy due to a rebound effect in Ghana, Malawi, and Gabon
Abstract Background RTS, S/AS01 is the first malaria vaccine to be approved and
recommended for widespread implementation by the World Health Organization (WHO) …
recommended for widespread implementation by the World Health Organization (WHO) …
[HTML][HTML] Modelling the relative cost-effectiveness of the RTS, S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis
Abstract Background The World Health Organization has recommended a 4-dose schedule
of the RTS, S/AS01 (RTS, S) vaccine for children in regions of moderate to high P …
of the RTS, S/AS01 (RTS, S) vaccine for children in regions of moderate to high P …
Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS, S/AS01 vaccine
In modern medicine, vaccination is one of the most effective public health strategies to
prevent infectious diseases. Indisputably, vaccines have saved millions of lives by reducing …
prevent infectious diseases. Indisputably, vaccines have saved millions of lives by reducing …
[HTML][HTML] Malaria Burden Stratification in Malawi-A report of a consultative workshop to inform the 2023-2030 Malawi Malaria Strategic Plan
D Mategula, C Mitambo, W Sheahan… - Wellcome Open …, 2023 - ncbi.nlm.nih.gov
Background: Malawi's National Malaria Control Programme (NMCP) is developing a new
strategic plan for 2023-2030 to combat malaria and recognizes that a blanket approach to …
strategic plan for 2023-2030 to combat malaria and recognizes that a blanket approach to …
Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
Abstract Background The RTS, S/AS01 malaria vaccine is currently being evaluated in a
cluster-randomized pilot implementation programme in three African countries. This study …
cluster-randomized pilot implementation programme in three African countries. This study …
Environmental modifiers of RTS, S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
Abstract Background RTS, S/AS01 is the first vaccine against malaria to undergo pilot
implementation, beginning in 2019 and vaccinating 360,000 children per year in Malawi …
implementation, beginning in 2019 and vaccinating 360,000 children per year in Malawi …
Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review
The Immunization Agenda 2030 prioritizes the populations without access to vaccines.
Health equity has been increasingly incorporated into economic evaluations of vaccines to …
Health equity has been increasingly incorporated into economic evaluations of vaccines to …
An Investment Case for the Scale-up and Use of Insecticide-Treated Nets Halfway into the SDG Targets
R Shretta, RN Anye - Journal of Benefit-Cost Analysis, 2023 - cambridge.org
This article examines a policy of scaling up LLINs by 10 percentage points from 2020 levels
with a 90% cap in the 29 highest-burden countries in Africa along with social and behavioral …
with a 90% cap in the 29 highest-burden countries in Africa along with social and behavioral …